In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 9, 2012, Pages 2382-2391

  Hernández, Antonio ^a,b   Reyes, Ricardo ^a   Sánchez, Esther ^a   Rodríguez Évora, María ^a   Delgado, Araceli ^a   Évora, Carmen ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITEN Rambla   (Spain)

Author keywords

BMP 2; bone regeneration; delivery system; PLGA; VEGF

Indexed keywords

BMP-2; BONE REGENERATION; DELIVERY SYSTEMS; PLGA; VEGF;

DEFECTS;

BONE;

BONE MORPHOGENETIC PROTEIN 2; MICROSPHERE; POROUS POLYMER; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE REGENERATION; BONE REMODELING; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RELEASE; FEMUR FRACTURE; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; NONHUMAN; RABBIT; RAT; VASCULARIZATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; DRUG CARRIERS; FEMUR; LACTIC ACID; POLYGLYCOLIC ACID; POROSITY; RABBITS; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864415764     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34183     Document Type: Article

References (30)

1. Lieberman JR, Daluiski A, Einhorn TA,. The role of growth factors in the repair of bone. J Bone Joint Surg 2002; 84: 1032-1044.
2. Chao TJ, Gerstenfeld LC, Einhorn TA,. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 2002; 17: 513-520.
3. Tatsuyama K, Maezawa Y, Baba H, Imamura Y, Fukuda M,. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem 2000; 44: 269-278.
4. Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarmann HJTHM,. Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 2005; 87: 1367-1378.
5. Bessa PC, Casal M, Reis RL,. Bone morphogenetic proteins in tissue engineering: The road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008; 2: 1-13.
6. Bessa PC, Casal M, Reis RL,. Bone morphogenetic proteins in tissue engineering: The road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008; 2: 81-96.
7. Diederik HR, Kempen MD, Creemers LB, Alblas J, Lu L, Verbout AJ, Yaszemski MJ, Dhert JAW,. Growth factor interactions in bone regeneration. Tissue Eng B 2010; 16: 551-566.
8. Kanczler JM, Oreffo ROC,. Osteogenesis and angiogenesis: The potential for engineering. Bone Eur Cells Mater 2008; 15: 100-114.
9. Street J, Bao M, de Guzman L, Bunting S, Peale FV, Ferrara N Jr, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RAD, Filvaroff EH,. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002; 99: 9656-9661.
10. Geris L, Gerisch A, Sloten JV, Weiner R, Oosterwyck HV,. Angiogenesis in bone fracture healing: A bioregulatory model. J Theor Biol 2008: 251: 137.
11. Eckardt H, Ding M, Lind M, Hansen ES, Christensen KS, Hvid I,. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 2005; 87: 1434-1438.
12. Peng H, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, Huard J,. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005; 20: 2017-2027.
13. Kakudo N, Kusumoto K, Wang YB, Iguchi Y, Ogawa Y,. Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2. Life Sci 2006; 79: 1847-1857.
14. Kanczler JM, Ginty PJ, White L, Clarke NMP, Howdle SM, Shakesheff KM, Oreffo ROC,. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 2010; 31: 1242-1250.
15. Young S, Patel ZS, Kretlow JD, Murphy MB, Mountziaris PM, Baggett LS, Ueda H, Tabata Y, Jansen JA, Wong M, Mikos AG,. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng A 2009; 15: 2347-2362.
16. Patel ZS, Young S, Tabata Y, Jansen JA, Wong MEK, Mikos AG,. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008; 43: 931-940.
17. Kempen DHR, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WAJ,. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009; 30: 2816-2825.
18. Yoon JJ, Park TG,. Degradation behaviors of biodegradable macroporous scaffolds prepared by gas foaming of effervescent salts. J Biomed Mater Res 2001; 55: 401-408.
19. De la Riva B, Nowak C, Sánchez E, Hernández A, Schulz-Siegmund M, Pec MK, Delgado A, Evora C,. VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. Eur J Pharm Biopharm 2009; 73: 50-58.
20. Huang Z, Ren P-G, Ma T, Smith RL, Goodman SB,. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 2010; 51: 305-310.
21. Dobson KR, Reading L, Haberey M, Marine X, Scutt A,. Centrifugal isolation of bone marrow from bone: An improved method for the recovery and quantitation of bone marrow osteoprogenitor cells rat tibiae and femurae. Calcif Tissue Int 1999; 65: 411-413.
22. Baro M, Sánchez A, Delgado A, Perera A, Evora C,. In vitro-in vivo characterization of gentamicin bone implants. J Control Release 2002; 83: 353-364.
23. Delgado JJ, Evora C, Sánchez E, Baro M, Delgado A,. Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in bone. J Control Release 2006; 114: 223-229.
24. Hernández A, Sánchez E, Soriano I, Reyes R, Delgado A, Evora C,. Material-related effects of BMP-2delivery systems on bone regeneration. Acta Biomater 2012; 8: 781-791.
25. Jeon O, Song SJ, Yang HS, Bhang S-H, Kang S-W, Sung MA, Lee JH, Kim B-S,. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 2008; 369: 774-780.
26. Dimitriou R, Tsiridis E, Giannoudis PV,. Current concepts of molecular aspects of bone healing. Injury 2005; 36: 1392-1404.
27. Phillips AM,. Overview of the fracture healing cascade. Injury 2005; 36S: S5-S7.
28. Pufe T, Wildemann B, Petersen W, Mentlein R, Raschke M, Schmidmaier G,. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: A study in the rat. Cell Tissue Res 2002; 309: 387-392.
29. Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, Nagashima M, Nakamura T,. Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 2003; 32: 491-501.
30. Roldán JC, Detsch R, Schaefer S, Chang E, Kelantan M, Waiss W, Reichert TE, Gurtner GC, Deisinger U,. Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model. J Craniomaxillofac Surg 2010; 38: 423-430.